LNTH
Lantheus Holdings Inc
NASDAQ: LNTH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$100.10
-0.05% today
Updated 2026-10-28
Market cap
$6.51B
P/E ratio
24.14
P/S ratio
4.18x
EPS (TTM)
$4.13
Dividend yield
—
52W range
$50 – $112
Volume
1.1M
Lantheus Holdings Inc (LNTH) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$100.10
12-Month target
$73.66
2030 Target
—
Intrinsic (DCF)
$66.49
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.4B | $0.9B | $1.3B | $1.5B | $1.5B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 24.14x (capped 25x) · Margin: 17.70%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.